Safety of Pediatric COVID-19 Vaccination
A Prospective Observational Study to Evaluate the Safety of COVID-19 Vaccination in Children and Adolescents
Sponsor: Centers for Disease Control and Prevention
Listed as NCT05157191, this observational or N/A phase trial focuses on Adverse Drug Event and Injection Site Reaction and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 11 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Dec 2024 — Present [monthly]
Completed
-
Sep 2024 — Dec 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
-
Jan 2024 — May 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Aug 2023 — Jan 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2023 — Aug 2023 [monthly]
Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Recruiting
-
May 2022 — Jul 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2022 — May 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centers for Disease Control and Prevention
- Children's Hospital Medical Center, Cincinnati
- Columbia University
- Duke University
- Kaiser Permanente
For direct contact, visit the study record on ClinicalTrials.gov .